<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04427371</url>
  </required_header>
  <id_info>
    <org_study_id>SoutheastUChina</org_study_id>
    <nct_id>NCT04427371</nct_id>
  </id_info>
  <brief_title>The Effect and Mechanism of lncRNA NBR2 Regulating Endothelial Pyroptosis by Targeting GSDMD in Sepsis</brief_title>
  <official_title>Zhongda Hospital, School of Medicine, Southeast University</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jianfeng Xie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sepsis is a life-threatening disease characterized by multi-organ failure due to dysregulated&#xD;
      host response to infection, with high global mortality of 30-50%. One of the most important&#xD;
      pathophysiologic hallmarks in sepsis is vascular endothelial injury that contributes to the&#xD;
      severity and outcome of the syndrome. Effective treatments for endothelial cell injury in&#xD;
      sepsis have been lacking to improve prognosis. Endothelial pyroptosis is a vital mechanism of&#xD;
      vascular endothelial injury in sepsis; mitigation or abolishment of endothelial cell&#xD;
      pyroptosis alleviate vascular endothelial damage and improve the prognosis of sepsis mice.&#xD;
      Gasdermin D (GSDMD) mediated endothelial pyroptosis plays a critical role in modulating&#xD;
      vascular endothelial injury in sepsis.&#xD;
&#xD;
      Long non-coding RNA (lncRNA), as a class of non-coding protein RNA longer than 200 kD,&#xD;
      contributes to a variety of cell biological processes. The dysregulation of lncRNA results in&#xD;
      the occurrence and development of tumors, diabetes, sepsis and other diseases. Therefore, we&#xD;
      detected lncRNA and mRNA expression profile in 26 blood samples of septic patients using&#xD;
      Arraystar LncRNA Microarray. We found lncRNA NBR2 regulates septic endothelial pyroptosis.&#xD;
&#xD;
      To assess any correlation of pyroptosis levels with relevant endothelial cell injury&#xD;
      parameters and determine the prognostic value in septic patients. we measured the levels of&#xD;
      pyroptosis in patients admitted to the Department of Critical Care Medicine for sepsis and&#xD;
      investigated the correlation with related markers of endothelium injury. Furthermore, we&#xD;
      determined the prognostic value of pyroptosis levels for the mortality of patients with&#xD;
      sepsis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We measured the levels of pyroptosis in patients admitted to the Department of Critical Care&#xD;
      Medicine for sepsis and investigated the correlation with related markers of endothelium&#xD;
      injury. Furthermore, we determined the prognostic value of pyroptosis levels for the&#xD;
      mortality of patients with sepsis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28-day</time_frame>
    <description>all-cause 28-day mortality</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>survivors</arm_group_label>
    <description>Improve or under treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nonsurvivors</arm_group_label>
    <description>all-cause 28-day mortality</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>the levels of pyroptosis</intervention_name>
    <description>Blood samples were taken to detect plasma lncRNA NBR2 levels and GSDMD protein level.</description>
    <arm_group_label>nonsurvivors</arm_group_label>
    <arm_group_label>survivors</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        sepsis was defined according to &quot;sepsis 3.0&quot;, which including suspected or confirmed&#xD;
        infection and increased SOFA â‰¥ 2, confirmed by two experienced intensive care physicians.&#xD;
        The infection was defined on the basis of infection sites, clinical features, clinical&#xD;
        microbiology, and imaging tests. Septic shock was defined as a vasopressor requirement to&#xD;
        maintain a mean arterial pressure of 65 mmHg or greater and serum lactate level greater&#xD;
        than 2 mmol/L in the absence of hypovolemia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Suspected or confirmed infection&#xD;
&#xD;
          -  The sequential organ failure score (SOFA score) increases by more than or equal to 2&#xD;
             points on the basis&#xD;
&#xD;
          -  Sign the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. the age &lt; 18 or &gt; 80 years of age&#xD;
&#xD;
          2. pregnant&#xD;
&#xD;
          3. tumor&#xD;
&#xD;
          4. viral hepatitis or liver cirrhosis&#xD;
&#xD;
          5. chronic renal tubular nephritis, chronic renal insufficiency&#xD;
&#xD;
          6. ulcerative colitis or crohn's disease&#xD;
&#xD;
          7. active systemic lupus erythematosus (SLE)&#xD;
&#xD;
          8. acute myocardial infarction&#xD;
&#xD;
          9. acute pancreatitis&#xD;
&#xD;
         10. engaged in other clinical subjects&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fei Peng, Dr</last_name>
    <phone>025-83262553</phone>
    <email>afei0312@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yi Yang, Prof.</last_name>
    <phone>025-83262553</phone>
    <email>yiyiyang2004@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongda Hospital, School of Medicine, Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fei Peng, Dr</last_name>
      <phone>025-83262553</phone>
      <email>afei0312@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 9, 2020</study_first_submitted>
  <study_first_submitted_qc>June 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2020</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jianfeng Xie</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>endothelial cell injury</keyword>
  <keyword>pyroptosis</keyword>
  <keyword>lncRNA NBR2</keyword>
  <keyword>gasdermin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

